| 000 | 02486 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250517063347.0 | ||
| 264 | 0 | _c20161031 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.6310 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWu, Xiao Yu | |
| 245 | 0 | 0 |
_aFormononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. _h[electronic resource] |
| 260 |
_bOncotarget _cDec 2015 |
||
| 300 |
_a44563-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xblood supply |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 |
_aChorioallantoic Membrane _xblood supply |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aIsoflavones _xpharmacology |
| 650 | 0 | 4 | _aMCF-7 Cells |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeovascularization, Pathologic |
| 650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSTAT3 Transcription Factor _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSunitinib |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aXu, Hao | |
| 700 | 1 | _aWu, Zhen Feng | |
| 700 | 1 | _aChen, Che | |
| 700 | 1 | _aLiu, Jia Yun | |
| 700 | 1 | _aWu, Guan Nan | |
| 700 | 1 | _aYao, Xue Quan | |
| 700 | 1 | _aLiu, Fu Kun | |
| 700 | 1 | _aLi, Gang | |
| 700 | 1 | _aShen, Liang | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 42 _gp. 44563-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.6310 _zAvailable from publisher's website |
| 999 |
_c25454917 _d25454917 |
||